Showing 31 - 40 of 51,814
Biotechnology firms operate in a highly innovative and capital-intensive environment, characterized by high levels of R&D, long product development periods, significant regulations, and high levels of uncertainty. These firms rely heavily on intangible assets, such as intellectual capital and...
Persistent link: https://www.econbiz.de/10015338290
Persistent link: https://www.econbiz.de/10015153613
High-tech firms are built much more on the intellectual capital of key personnel than on physical assets, and firms built around the best scientists are most likely to be successful in commercializing breakthrough technologies. As a result, such firms are expected to have higher market values...
Persistent link: https://www.econbiz.de/10012471587
We examine the relationship between the intellectual capital of scientists making frontier discoveries, the presence of great university bioscience programs, the presence of venture capital firms, other economic variables, and the founding of U.S. biotechnology enterprises during 1976-1989....
Persistent link: https://www.econbiz.de/10012474283
Persistent link: https://www.econbiz.de/10010235549
We examine the relationship between the intellectual capital of scientists making frontier discoveries, the presence of great university bioscience programs, the presence of venture capital firms, other economic variables, and the founding of U.S. biotechnology enterprises during 1976-1989....
Persistent link: https://www.econbiz.de/10013238946
High-tech firms are built much more on the intellectual capital of key personnel than on physical assets, and firms built around the best scientists are most likely to be successful in commercializing breakthrough technologies. As a result, such firms are expected to have higher market values...
Persistent link: https://www.econbiz.de/10013243425
In the context of the emergence of new modular organizational forms, especially in high-tech sectors such as the biotechnology sector, this article proposes that while a firm observes benefits from direct alliances, it also benefits from indirect linkages. First, a theoretical framework...
Persistent link: https://www.econbiz.de/10014028177
The objective of the study was to empirically verify impacts of intellectual capital (IC) to the anticipated future sales of small- and medium-sized companies within the biotechnology industry. The study creates and develops tools for the valuation of companies by relating the existing...
Persistent link: https://www.econbiz.de/10014028178
Persistent link: https://www.econbiz.de/10013484806